Join the 200th Anniversary Celebration

Original Article

A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners

Isabelle De Vincenzi for the European Study Group on Heterosexual Transmission of HIV

N Engl J Med 1994; 331:341-346August 11, 1994

Abstract

Background

Worldwide, the predominant mode of human immunodeficiency virus (HIV) transmission is heterosexual intercourse, but the risk of heterosexual transmission and the effectiveness of measures to prevent it are not well defined.

Methods

We conducted a prospective study of HIV-negative subjects whose only risk of HIV infection was a stable heterosexual relationship with an HIV-infected partner. Every six months the subjects were interviewed, tested for HIV, and counseled about safe sexual practices.

Results

A total of 304 HIV-negative subjects (196 women and 108 men) were followed for an average of 20 months. During the study, 130 couples (42.8 percent) ended their sexual relationships, most often because of the HIV-infected partner's illness or death. Of the 256 couples who continued to have sexual relations for more than three months after enrollment in the study, only 124 (48.4 percent) used condoms consistently for vaginal and anal intercourse. Among these couples, none of the seronegative partners became infected with HIV, despite a total of about 15,000 episodes of intercourse. Among the 121 couples who used condoms inconsistently, the rate of seroconversion was 4.8 per 100 person-years (95 percent confidence interval, 2.5 to 8.4). Eleven couples refused to answer questions about condom use. The risk of transmission increased with advanced stages of HIV infection in the index partners (P<0.02) and with genital infection in the HIV-negative partners (P<0.04). Withdrawal to avoid ejaculation in the vagina had a protective effect in uninfected women (P<0.02).

Conclusions

Consistent use of condoms for heterosexual intercourse is highly effective in preventing the transmission of HIV. Among couples not using condoms regularly, the risk of HIV transmission varies widely. .

Media in This Article

Figure 1Sexual Practices among 124 Couples Using Condoms Consistently (Solid Bars) and 121 Couples Using Condoms Inconsistently (Open Bars).
Table 1Couples Lost to Follow-up, According to Characteristics at the Time of Enrollment in the Study.
Article

Worldwide, the predominant mode of human immunodeficiency virus (HIV) transmission is heterosexual intercourse. Knowledge of the rates of transmission, the risk factors for transmission, and the effectiveness of preventive methods is essential for both the design and the evaluation of prevention programs1. Several studies have examined the prevalence of HIV infection among partners of HIV-infected people and the risk factors for sexual transmission of the virus. However, few of these studies have been longitudinal2-4.

Although the use of condoms is still the only available method to prevent HIV infection in people who have sexual contact with HIV-infected partners, the effectiveness of condoms in preventing infection is not known with precision5. The incidence of condom breakage during vaginal intercourse has been estimated at around 1 percent,6 but most cases of sexual transmission among couples using condoms are related to inconsistent use of condoms rather than to failure of the barrier method itself5.

A cross-sectional analysis of data from a multicenter European study examined the risk factors for both male-to-female and female-to-male transmission of HIV7. We present here the prospective component of that study, which includes follow-up data on couples in which one partner was HIV-positive and the other was HIV-negative. The aims of the longitudinal study were to determine the rate of condom use after counseling, the effectiveness of condoms in preventing HIV transmission, and the rate of and risk factors for transmission among couples who did not use condoms consistently.

Methods

Between March 1987 and March 1991, HIV-infected men and women (index partners) and their heterosexual partners were recruited in hospital wards, outpatient clinics, clinics for the treatment of sexually transmitted diseases, and local public health departments (HIV-screening centers and drug-treatment centers). The study excluded occasional partners and partners with other risk factors for HIV infection (intravenous drug use, male homosexual relations, receipt of unscreened blood products, sexual contact with multiple partners, or one or more heterosexual partners who were from sub-Saharan Africa or had one of the above risk factors). Study participants were interviewed with the use of a standardized questionnaire translated from English into the language used at the participating center. The index partners underwent HIV testing at the time of enrollment in the study, and their HIV-seronegative partners were seen every six months, until June 1992. A total of 378 couples recruited at 10 centers in eight countries of the European Community were eligible for the prospective study.

At each visit, the couples were counseled about the risk of HIV infection and about safe sexual practices, according to the policies at the center. At follow-up visits, to avoid any influence of knowledge of the HIV-test results on the reporting of sexual behavior, the partners were interviewed before being told the results. For each follow-up period, the subjects were asked about their history of risk factors for HIV infection, the number of sexual partners, contraceptive practices, use of condoms, and sexual practices. A history of sexually transmitted diseases was also obtained.

HIV serologic status was determined by the enzyme-linked immunosorbent assay and confirmed by Western blotting or radioimmunoprecipitation in the laboratories of the participating centers. Information on the index partners' clinical status, according to the classification of the Centers for Disease Control and Prevention (CDC),8 and lymphocyte counts per cubic millimeter was obtained from medical records.

Partners seen at least twice (at enrollment and at least one follow-up visit) were included in the study. The duration of exposure to HIV was defined as the time from enrollment in the study to the last negative HIV test, for subjects who remained uninfected and still had sexual contact with their infected partners in June 1992; the time to the last sexual contact, for subjects who remained uninfected but ceased sexual relations with their infected partners; or the midpoint between the last negative test and the first positive test, for subjects who seroconverted. The frequency of condom use during follow-up was estimated as the mean of the frequencies reported during the follow-up visits.

Factors linked to loss of follow-up, cessation of sexual contact, and frequency of condom use were analyzed with Fisher's exact test and the chi-square test for categorical variables and with Student's t-test for continuous variables. Multivariate analyses were computed by logistic regression. Calculation of the 95 percent confidence intervals for rates of seroconversion according to person-years was based on the Poisson distribution. Risk factors for seroconversion were analyzed among the subsample of couples who had unprotected sexual contact during the study, with the use of the actuarial life-table method, and survival curves were compared with the use of the Breslow test9.

Results

Of the 378 eligible couples, 256 (67.7 percent) continued to have sexual relations (93 with female index partners and 163 with male index partners), 48 (12.7 percent) ceased having sexual relations within three months after their first visit, and 74 (19.6 percent) were lost to follow-up. The proportion of couples lost to follow-up was not significantly associated with the center (range, 5 to 31 percent) or with any of the sexual, demographic, or medical characteristics documented at the time of enrollment (Table 1Table 1Couples Lost to Follow-up, According to Characteristics at the Time of Enrollment in the Study.).

Continuation of Sexual Relations

A total of 130 couples (42.8 percent) ceased having sexual relations during the study period. Forty-eight couples stopped having sexual contact within three months after enrollment, and 82 couples did so later during the follow-up period. In nearly one third of these couples (40 of 130), the index partners had died. In 19 of the remaining 90 couples (21.1 percent), the index partners had AIDS. In comparison, the index partners had AIDS in only 18 of the 174 couples (10.3 percent) who continued to have sexual relations (P<0.02). Among the couples with asymptomatic index partners, the initially uninfected partners tended to be younger in the couples who continued to have sexual relations than in the couples who did not (median age, 28 vs. 30 years; P<0.05). The couples continuing to have sexual relations also had more frequent sexual contact before the positive HIV test of the index partner (median number of contacts per week, three vs. two; P<0.01) and were more likely to use condoms after the positive test (92 percent vs. 77 percent; P<0.05). The continuation of sexual relations was not associated with the sex of the index partner, the mode of infection in the index partner, or the previous duration of the relationship.

Subsequent analyses concern the 256 couples who continued to have sexual contact for more than three months after enrollment in the study. The median duration of exposure to infection for the 256 uninfected partners was 22 months.

Frequency of Condom Use

The 256 couples were classified according to the frequency of condom use during follow-up. Only 124 couples (48.4 percent) used condoms for every episode of vaginal or anal intercourse (consistent condom users); 121 couples (47.3 percent) did not always use condoms (inconsistent condom users). Among the 121 couples who were inconsistent users, 61 (50.4 percent) used condoms for at least half their sexual contacts but not for every contact, and 60 (49.6 percent) rarely or never used condoms. Eleven of the 256 couples (4.3 percent) refused to answer questions about their sexual behavior, although the uninfected partners agreed to follow-up serologic testing.

In the univariate analysis (Table 2Table 2Rate of Consistent Condom Use, According to the Characteristics of the Index Partner, the Duration of the Relationship, and the Duration of Follow-up.), consistent condom use was not associated with the age or sex of the index partner or with the duration of follow-up. The median duration of the relationship before enrollment in the study was longer among the consistent users than among the inconsistent users (36 vs. 24 months, P<0.01). Consistent use of condoms was more frequent among couples in which the index partner had received a diagnosis of AIDS before enrollment in the study (70.8 percent vs. 48.4 percent, P<0.04). The proportion of consistent condom users varied according to the mode of infection in the index partner, ranging from 40.1 percent for infection through drug use to 73.2 percent for infection through sexual contact. The proportion of consistent condom users varied according to the enrolling center (range, 18 to 79 percent). To take into account the associations among these variables, all were included in a logistic-regression model. After adjustment for the center, the mode of infection in the index partner (P<0.001), the clinical status of the index partner at the time of enrollment (P<0.05), and the duration of the relationship before enrollment (P<0.04) were independently associated with consistent condom use.

The other modifications in sexual behavior recorded during the study included a decreasing frequency of sexual contacts and the cessation of anal sex, sex during menses, and oral sex. Throughout the study, the consistent condom users reported a lower frequency of sexual contacts and lower frequencies of oral and anal sex and sex during menses than did the inconsistent users (Figure 1Figure 1Sexual Practices among 124 Couples Using Condoms Consistently (Solid Bars) and 121 Couples Using Condoms Inconsistently (Open Bars).).

Seroconversion Rates

Seroconversion occurred in 12 of the 256 partners followed (8 women and 4 men), for a seroconversion rate of 2.3 per 100 person-years (95 percent confidence interval, 1.2 to 4.0) for the whole group.

No seroconversion occurred among the 124 couples who used condoms for each vaginal or anal contact (95 percent confidence interval, 0 to 1.5 per 100 personyears). These 124 couples had approximately 15,000 protected sexual contacts during the study. Among these couples, 49 (39.5 percent) continued to practice fellatio, and 39 of the 49 did so without the use of condoms. The 95 percent confidence interval for the null rate of seroconversion through unprotected fellatio was 0 to 4.7 per 100 person-years.

No seroconversion occurred among the 11 couples who did not provide information on condom use.

Risk Factors for Seroconversion among Inconsistent Condom Users

Twelve initially uninfected partners seroconverted among the 121 couples using condoms inconsistently for vaginal or anal sex, corresponding to a seroconversion rate of 4.8 per 100 person-years (95 percent confidence interval, 2.5 to 8.4).

Since none of the seroconversions occurred after 24 months of exposure, the estimated cumulative incidence of seroconversion at 24 months is presented here. However, the statistical test relies on a global comparison of the survival curves. The estimated cumulative incidence of seroconversion at 24 months among the 121 inconsistent condom users was 12.7 percent (95 percent confidence interval, 5.9 to 19.5). In the univariate analysis (Table 3Table 3Cumulative Rate of Seroconversion at 24 Months among the 121 Couples Not Consistently Using Condoms.), the cumulative incidence of seroconversion did not differ significantly between the female and male index partners (11.4 and 13.4 percent, respectively).

The cumulative incidence of seroconversion differed significantly according to the clinical status of the index partner (P<0.02). Among couples in which the index partner was in an advanced stage of infection at the time of enrollment in the study (stage IV in the CDC classification or a CD4 cell count below 200 per cubic millimeter), the cumulative incidence of seroconversion in the uninfected partner was 48.7 percent, as compared with 7.8 percent among the couples in which the index partner remained asymptomatic and had a CD4 count above 199 per cubic millimeter throughout the follow-up period. Among couples in which the infection in the index partner progressed from an asymptomatic stage at the time of enrollment (with a CD4 count >199 per cubic millimeter) to an advanced stage during follow-up, the estimated cumulative incidence of seroconversion in the uninfected partner was 11.7 percent.

Five nonindex partners reported ulcerative genital infections during follow-up, and nine nonindex partners reported nonulcerative infections. Three of the 12 partners who seroconverted had genital infections: 1 had balanitis, 1 a recurrence of herpes, and 1 syphilis (a woman whose HIV-infected partner had acquired syphilis from someone not included in the study). The cumulative incidence of seroconversion was significantly lower (P<0.04) among partners reporting no genital infections (12.8 percent) than among those reporting nonulcerative infections (33.3 percent) or ulcerative infections (40.0 percent).

Among the eight women who continued to have unprotected anal sex with their HIV-infected male partners, the cumulative incidence of seroconversion was 27.8 percent, as compared with 11.7 percent among the women not reporting such practices (P>0.15). The frequency of sexual contacts (median, two per week), the use of oral contraceptives, and the practice of oral sex and sex during menses were not associated with the risk of seroconversion. The couples using condoms for at least half but not all sexual contacts had about the same risk of seroconversion as the couples not using condoms (10.3 and 15.0 percent, respectively; P>0.60). On the other hand, withdrawal before ejaculation was associated with a lower risk of male-to-female transmission of HIV (P<0.02). The cumulative incidence of seroconversion was 0 percent among the couples who nearly always practiced withdrawal before ejaculation, 7.2 percent among those who did so about half the time, and 32.4 percent among those who rarely or never did so.

The number of subjects who seroconverted was too small to allow a multivariate analysis.

Discussion

It is reassuring that no HIV transmission occurred among the couples reporting consistent use of condoms. However, only half the couples who continued having sexual relations used condoms consistently. Since the counseling was not standardized, it is difficult to relate it to these results. Condoms were reported to have a low level of acceptability among drug users and their non-drug-using partners in New York,10 but not in a cohort of couples in California2.

There is still much debate about whether unprotected oral sex should be considered a safe sexual practice11. People with no risk factors for HIV infection other than unprotected oral sex with an infected partner represent an ideal population for the estimation of the risk of transmission by this practice. In our study, no seroconversion occurred in the small subsample of 39 partners who had unprotected oral sex while consistently using condoms during vaginal intercourse. The 95 percent confidence interval for this null rate of transmission is 0 to 4.7 per 100 person-years, representing a risk that, although significantly lower than the risk associated with unprotected vaginal intercourse, cannot be assumed to be negligible.

Attempts have been made to estimate the risk of transmission per episode of vaginal intercourse12,13. Our data, which are prospective rather than retrospective, allow a more reliable estimation of that risk, and the results of our analyses confirm that the risk is not constant from one contact to another. For example, among the 121 couples who used condoms inconsistently during an estimated 12,000 unprotected sexual contacts, the rate of transmission per contact was 1 per 1000 (95 percent confidence interval, 0.5 to 1.7). When the risk was estimated according to the stage of HIV infection in the index partner, the rate of transmission per contact was 5 per 1000 (95 percent confidence interval, 1.4 to 13.1) if the index partner was in an advanced stage of infection and 0.7 per 1000 (95 percent confidence interval, 0.3 to 1.4) if the index partner was asymptomatic. Thus, the clinical status of the HIV-infected partner greatly influences the risk of transmission per sexual contact, suggesting that some people are highly infectious and others hardly infectious at all. Repeated acts of unprotected sexual intercourse are not independent of one another. For example, if someone has had 100 sexual contacts with a partner who has a very low level of infectivity, the risk of transmission is low. However, if someone has sex with 100 different infected partners, there is a high probability that at least one of the partners is highly infectious.

The identification of risk factors for HIV is limited in the present analysis because of the small number of partners who seroconverted. Consequently, the power of the tests is low, and nonsignificant differences should be interpreted with caution. In particular, although no difference was found between the risk of male-to-female transmission and that of female-to-male transmission, one should not conclude that the risk of transmission is similar in both directions. Indeed, recent studies7,14 suggest that male-to-female transmission is twice as efficient as female-to-male transmission. Anal sex does not significantly increase the risk of transmission to the female partner15. This result could be due to a lack of power, since only eight women continued to have unprotected anal sex with their HIV-infected partners; the cumulative incidence of seroconversion among these women was 27.8 percent, as compared with 11.7 percent among the women who did not have unprotected anal sex.

Consistent withdrawal before ejaculation appears to provide female partners with some protection against HIV infection. The avoidance of contact between the infected sperm and the cervicovaginal mucosa, either by the use of condoms or by withdrawal before ejaculation, may provide a higher level of protection than that provided by inconsistent condom use alone. However, pre-ejaculatory fluid may be a vector for the transmission of HIV16. Moreover, withdrawal is less effective than condom use as a contraceptive measure (efficacy, 82 percent vs. 88 percent),17 and the potential protection is only against male-to-female transmission. Withdrawal as a method of protection relies solely on the action of the infected male partner, with no possibility of control by the female partner, and unlike condom use, withdrawal does not provide protection from other sexually transmitted diseases, which may be cofactors for the transmission of HIV1.

Despite the low power of this study, the data indicate that the stage of HIV infection in the index partner is a strong risk factor for transmission, confirming the results of previous studies7,18. Therefore, the variation in transmission rates among studies in different countries may be due, at least in part, to differences in the stage of the HIV epidemic and in the proportions of patients with advanced infection. In our study, there were too few index partners with an advanced stage of HIV infection to permit assessment of the potential protective effect of anti-HIV therapy18.

The results of our study add support to the view that genital infections, especially those that are ulcerative, facilitate the transmission of HIV1. Most of the genital infections in our subjects were caused by herpesvirus or candida. These infections occurred among consistent condom users as well as inconsistent users and thus may not have been acquired sexually during the study period. Since a genital examination was not performed systematically at each study visit, we cannot exclude the possibility that some genital infections were missed, but it is likely that the missed episodes were equally distributed among the subjects who seroconverted and those who did not, since the interviews were conducted before the subjects knew the HIV-test results.

Finally, it should be stressed that nearly half the couples (130 of 304) had stopped having sexual relations by the time the study ended, perhaps to protect themselves against the transmission of HIV. This phenomenon, together with the ethical requirements for counseling, limits what can be learned from longitudinal studies of sexual transmission between partners. It may be useful to examine the immunologic and virologic characteristics of the few couples who remain discordant for HIV infection despite high risks of transmission. The effectiveness of other preventive methods, including local microbicides, deserves further study in large populations at risk of acquiring HIV infection through sexual contact.

Supported by grants from the Commission of the European Communities.

We are indebted to M. Laga and A. Downs for their participation and advice.

Source Information

From the European Centre for the Epidemiological Monitoring of AIDS, Hopital National de Saint-Maurice, 14 rue du Val d'Osne, 94410 Saint-Maurice, France, where reprint requests should be addressed to Dr. de Vincenzi.

The members of the European Study Group on Heterosexual Transmission of HIV are listed in the Appendix.

Appendix

The European Study Group on Heterosexual Transmission of HIV includes the following centers and investigators: the European Centre for the Epidemiological Monitoring of AIDS, Hopital National de Saint-Maurice, Saint-Maurice, France (coordinating center): I. de Vincenzi, R.A. Ancelle-Park, and J.-B. Brunet; Istituto Malattie Infettive, Universita di Bologna, Bologna, Italy: P. Costigliola, E. Ricchi, and F. Chiodo; Athens School of Hygiene, Athens, Greece: A. Roumeliotou and G. Papaevangelou; Sozialpadagogisches Institut, Berlin, Germany: M. Kraus and W. Heckmann; Department of Public Health and Environment, Municipal Health Service, Amsterdam: R.A. Coutinho and H.J.A. van Haastrecht; Programa del SIDA, Generalitat de Catalunya, Barcelona, Spain: J. Casabona and J. Tor; Infectious Diseases Service, Health Institute Carlos III, Madrid: J. Gonzalez-Lahoz and R. Andres-Medina; Institute of Tropical Medicine, Antwerp, Belgium: M. Vandenbruaene and J. Goeman; Immunopathologie Clinique, Hopital H. Mondor, Creteil, France: A. Sobel; and Infectious Disease Unit, City Hospital, Edinburgh, United Kingdom: R. Brettle and R. Robertson.

References

References

  1. 1

    Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102
    CrossRef | Web of Science | Medline

  2. 2

    Padian NS, O'Brien TR, Chang Y, Glass S, Francis DP. Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr 1993;6:1043-1048
    Web of Science | Medline

  3. 3

    Kamenga M, Ryder RW, Jingu M, et al. Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in Zaire. AIDS 1991;5:61-67
    CrossRef | Web of Science | Medline

  4. 4

    Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr 1993;6:497-502
    Web of Science | Medline

  5. 5

    Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 1993;36:1635-1644
    CrossRef | Web of Science | Medline

  6. 6

    Chan-Chee C, De Vincenzi I, Sole-Pla MA, Ancelle-Park R, Brunet JB. Use and misuse of condoms. Genitourin Med 1991;67:173-173
    Medline

  7. 7

    European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992;304:809-813
    CrossRef | Web of Science

  8. 8

    Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infectionsMMWR Morb Mortal Wkly Rep 1986;35:334-339
    Medline

  9. 9

    Dixon WJ, ed. BMDP statistical software manual. Vol. 2. Berkeley: University of California, 1992:739-68.

  10. 10

    Siddiqui NS, Brown LS Jr, Phillips RY, Vargas O, Makuch RW. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City. AIDS 1992;6:1529-1533[Erratum, IDS 1993;7:following 444.]
    CrossRef | Web of Science | Medline

  11. 11

    Keet IP, Albrecht van Lent N, Sandfort TG, Coutinho RA, van Griensven GJ. Orogenital sex and the transmission of HIV among homosexual men. AIDS 1992;6:223-226
    CrossRef | Web of Science | Medline

  12. 12

    Kaplan EH. Modeling HIV infectivity: must sex acts be counted? J Acquir Immune Defic Syndr 1990;3:55-61
    Web of Science | Medline

  13. 13

    Wiley JA, Herschkorn SJ, Padian NS. Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse. Stat Med 1989;8:93-102
    CrossRef | Web of Science | Medline

  14. 14

    Haverkos HW, Battjes RJ. Female-to-male transmission of HIV. JAMA 1992;268:1855-1857
    CrossRef | Web of Science | Medline

  15. 15

    Voeller B. Heterosexual anal intercourse: an AIDS risk factor. In: Voeller B, Machover Reinisch J, Gottlieb M, eds. AIDS and sex: an integrated biomedical and biobehavioral approach. New York: Oxford University Press, 1990:276-310.

  16. 16

    Pudney J, Oneta M, Mayer K, Seage G III, Anderson D. Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet 1992;340:1470-1470
    CrossRef | Web of Science | Medline

  17. 17

    Rosenberg MJ, Gollub EL. Methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health 1992;82:1473-1478
    CrossRef | Web of Science | Medline

  18. 18

    Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 1992;267:2769-2774
    CrossRef | Web of Science | Medline

Citing Articles (242)

Citing Articles

  1. 1

    Renee Heffron, Deborah Donnell, Helen Rees, Connie Celum, Nelly Mugo, Edwin Were, Guy de Bruyn, Edith Nakku-Joloba, Kenneth Ngure, James Kiarie, Robert W Coombs, Jared M Baeten. (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. The Lancet Infectious Diseases 12:1, 19-26
    CrossRef

  2. 2

    G. M. Wingood, R. J. DiClemente, K. Villamizar, D. L. Er, M. DeVarona, J. Taveras, T. M. Painter, D. L. Lang, J. W. Hardin, E. Ullah, J. Stallworth, D. W. Purcell, R. Jean. (2011) Efficacy of a Health Educator-Delivered HIV Prevention Intervention for Latina Women: A Randomized Controlled Trial. American Journal of Public Health 101:12, 2245-2252
    CrossRef

  3. 3

    Karalyn McDonald. (2011) ‘The old-fashioned way’: conception and sex in serodiscordant relationships after ART. Culture, Health & Sexuality 13:10, 1119-1133
    CrossRef

  4. 4

    F. Kapadia, M. H. Latka, Y. Wu, S. A. Strathdee, M. E. Mackesy-Amiti, S. M. Hudson, H. Thiede, R. S. Garfein. (2011) Longitudinal Determinants of Consistent Condom Use by Partner Type Among Young Injection Drug Users: The Role of Personal and Partner Characteristics. AIDS and Behavior 15:7, 1309-1318
    CrossRef

  5. 5

    Felicia A. Browne, Wendee M. Wechsberg, J. Michael Bowling, Winnie K. Luseno. (2011) Correlates of Male Condom Use Skills among High-Risk Women in South Africa. Journal of Sex Research1-9
    CrossRef

  6. 6

    Nicole Stolte-Leeb, Roberta Loddo, Sophia Antimisiaris, Tina Schultheiss, Ulrike Sauermann, Monika Franz, Spyridon Mourtas, Christophe Parsy, Richard Storer, Paolo La Colla, Christiane Stahl-Hennig. (2011) Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of Macaques. AIDS Research and Human Retroviruses 27:9, 933-943
    CrossRef

  7. 7

    Julie Fox, Peter J White, Jonathan Weber, Geoff P Garnett, Helen Ward, Sarah Fidler. (2011) Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS 25:8, 1065-1082
    CrossRef

  8. 8

    Andrea R. Thurman, Gustavo F. Doncel. (2011) Innate Immunity and Inflammatory Response to Trichomonas vaginalis and Bacterial Vaginosis: Relationship to HIV Acquisition. American Journal of Reproductive Immunology 65:2, 89-98
    CrossRef

  9. 9

    Gina M. Wingood, Josephina J. Card, Deja Er, Julie Solomon, Nikia Braxton, Delia Lang, Puja Seth, Jim Cartreine, Ralph J. DiClemente. (2011) Preliminary efficacy of a computer-based HIV intervention for African-American women. Psychology & Health 26:2, 223-234
    CrossRef

  10. 10

    Valentina Cambiano, Alison J Rodger, Andrew N Phillips. (2011) ‘Test-and-treat’: the end of the HIV epidemic?. Current Opinion in Infectious Diseases 24:1, 19-26
    CrossRef

  11. 11

    Ahizechukwu C Eke, Chikelue Oragwu, Ahizechukwu C Eke. 2011. Sperm washing to prevent HIV transmission from HIV-infected men but allowing conception in sero-discordant couples. .
    CrossRef

  12. 12

    David R. Friend. (2010) Pharmaceutical development of microbicide drug products. Pharmaceutical Development and Technology 15:6, 562-581
    CrossRef

  13. 13

    Samuel Lurie. (2010) Does intercourse during menses increase the risk for sexually transmitted disease?. Archives of Gynecology and Obstetrics 282:6, 627-630
    CrossRef

  14. 14

    Lu Wang, Zeng Ge, Jing Luo, Duo Shan, Xing Gao, Guo-wei Ding, Jian-ping Zhou, Wen-sheng He, Ning Wang. (2010) HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:2, 232-238
    CrossRef

  15. 15

    R. F. Baggaley, R. G. White, M.-C. Boily. (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. International Journal of Epidemiology 39:4, 1048-1063
    CrossRef

  16. 16

    Michael S. Avidan, Adam C. Searleman, Martha Storandt, Chengjie Xiong, John C. Morris, Alex S. Evers. (2010) Cognitive Decline after Surgery and Illness. Anesthesiology 112:5, 1283-1285
    CrossRef

  17. 17

    J. B. Jemmott, L. S. Jemmott, G. T. Fong, K. H. Morales. (2010) Effectiveness of an HIV/STD Risk-Reduction Intervention for Adolescents When Implemented by Community-Based Organizations: A Cluster-Randomized Controlled Trial. American Journal of Public Health 100:4, 720-726
    CrossRef

  18. 18

    J. A. Higgins, S. Hoffman, S. L. Dworkin. (2010) Rethinking Gender, Heterosexual Men, and Women's Vulnerability to HIV/AIDS. American Journal of Public Health 100:3, 435-445
    CrossRef

  19. 19

    R.J. DiClemente, G.M. Wingood, E. Rose, J.M. Sales, R.A. Crosby. (2010) Evaluation of an HIV/STD Sexual Risk-Reduction Intervention for Pregnant African American Adolescents Attending a Prenatal Clinic in an Urban Public Hospital: Preliminary Evidence of Efficacy. Journal of Pediatric and Adolescent Gynecology 23:1, 32-38
    CrossRef

  20. 20

    A. Vandermaelen, Y. Englert. (2010) Human immunodeficiency virus serodiscordant couples on highly active antiretroviral therapies with undetectable viral load: conception by unprotected sexual intercourse or by assisted reproduction techniques?. Human Reproduction 25:2, 374-379
    CrossRef

  21. 21

    Jessica M. Sales, Delia L. Lang, James W. Hardin, Ralph J. DiClemente, Gina M. Wingood. (2010) Efficacy of an HIV Prevention Program Among African American Female Adolescents Reporting High Depressive Symptomatology. Journal of Women's Health 19:2, 219-227
    CrossRef

  22. 22

    Thuong Vu Nguyen, Nghia Van Khuu, Phong Hoai Truong, Anh Phuong Nguyen, Lien Xuan Thi Truong, Roger Detels. (2009) Correlation Between HIV and Sexual Behavior, Drug Use, Trichomoniasis and Candidiasis Among Female Sex Workers in a Mekong Delta Province of Vietnam. AIDS and Behavior 13:5, 873-880
    CrossRef

  23. 23

    Stephen J Genuis. (2009) Adolescent sexual behaviour and public health: the religion versus science dichotomy. Acta Paediatrica
    CrossRef

  24. 24

    Jennifer R. Horner, Laura F. Salazar, Daniel Romer, Peter A. Vanable, Ralph DiClemente, Michael P. Carey, Robert F. Valois, Bonita F. Stanton, Larry K. Brown. (2009) Withdrawal (Coitus Interruptus) as a Sexual Risk Reduction Strategy: Perspectives from African-American Adolescents. Archives of Sexual Behavior 38:5, 779-787
    CrossRef

  25. 25

    Joanne E. Mantell, Elizabeth A. Kelvin, Theresa M. Exner, Susie Hoffman, Sarah Needham, Zena A. Stein. (2009) Anal use of the female condom: does uncertainty justify provider inaction?. AIDS Care 21:9, 1185-1194
    CrossRef

  26. 26

    Lynn T. Matthews, Joia S. Mukherjee. (2009) Strategies for Harm Reduction Among HIV-Affected Couples Who Want to Conceive. AIDS and Behavior 13:S1, 5-11
    CrossRef

  27. 27

    G. Anita Heeren, John B. Jemmott, Andrew Mandeya, Joanne C. Tyler. (2009) Sub-Saharan African University Students’ Beliefs about Condoms, Condom-use Intention, and Subsequent Condom Use: A Prospective Study. AIDS and Behavior 13:2, 268-276
    CrossRef

  28. 28

    Charles S. Morrison, Abigail Norris Turner, LaShawn B. Jones. (2009) Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Practice & Research Clinical Obstetrics & Gynaecology 23:2, 263-284
    CrossRef

  29. 29

    Sharon R. Sznitman, Daniel Romer, Larry K. Brown, Ralph J. DiClemente, Robert F. Valois, Peter A. Vanable, Michael P. Carey, Bonita Stanton. (2009) Prevalence, Correlates, and Sexually Transmitted Infection Risk Related to Coitus Interruptus Among African-American Adolescents. Sexually Transmitted Diseases 36:4, 218-220
    CrossRef

  30. 30

    Sarra L. Hedden, Damiya Whitaker, Leah Floyd, William W. Latimer. (2009) Gender Differences in the Prevalence and Behavioral Risk Factors of HIV in South African Drug Users. AIDS and Behavior 13:2, 288-296
    CrossRef

  31. 31

    Marie-Claude Boily, Rebecca F Baggaley, Lei Wang, Benoit Masse, Richard G White, Richard J Hayes, Michel Alary. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. The Lancet Infectious Diseases 9:2, 118-129
    CrossRef

  32. 32

    Helen E. Cejtin. (2008) Gynecologic Issues in the HIV-Infected Woman. Infectious Disease Clinics of North America 22:4, 709-739
    CrossRef

  33. 33

    Matthew F Chersich, Helen V Rees. (2008) Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS 22:Suppl 4, S27-S40
    CrossRef

  34. 34

    O. Heikinheimo, P. Lahteenmaki. (2008) Contraception and HIV infection in women. Human Reproduction Update 15:2, 165-176
    CrossRef

  35. 35

    Keith Nathaniel Partington. (2008) Heterosexual HIV transmission: ethics of disinformation and the importance of adhering to an evidence-based approach in psychotherapeutic practice. Sexual and Relationship Therapy 23:4, 419-432
    CrossRef

  36. 36

    &NA;. (2008) Methodological Overview of an African American Couple-Based HIV/STD Prevention Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:Supplement 1, S3-S14
    CrossRef

  37. 37

    T. Déirdre Hollingsworth, Roy M. Anderson, Christophe Fraser. (2008) HIV-1 Transmission, by Stage of Infection. The Journal of Infectious Diseases 198:5, 687-693
    CrossRef

  38. 38

    Kamal Desai, Stephanie L Sansom, Marta L Ackers, Scott R Stewart, H Irene Hall, Dale J Hu, Rachel Sanders, Carol R Scotton, Sada Soorapanth, Marie-Claude Boily, Geoffrey P Garnett, Peter D McElroy. (2008) Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 22:14, 1829-1839
    CrossRef

  39. 39

    David P Wilson, Matthew G Law, Andrew E Grulich, David A Cooper, John M Kaldor. (2008) Relation between HIV viral load and infectiousness: a model-based analysis. The Lancet 372:9635, 314-320
    CrossRef

  40. 40

    Valeria Savasi, Bina Parrilla, Martina Ratti, Enrico Ferrazzi. (2008) Reproductive assistance in HIV-1 discordant couples. Current Opinion in Obstetrics and Gynecology 20:3, 205-210
    CrossRef

  41. 41

    Shelley Miksis. (2008) A Review of the Evidence Comparing the Human Papillomavirus Vaccine Versus Condoms in the Prevention of Human Papillomavirus Infections. Journal of Obstetric, Gynecologic, & Neonatal Nursing 37:3, 329-337
    CrossRef

  42. 42

    Lawrence W Green, Ryan G McAllister, Kent W Peterson, John W Travis. (2008) Male circumcision is not the HIV ‘vaccine’ we have been waiting for!. Future HIV Therapy 2:3, 193-199
    CrossRef

  43. 43

    Tahaniyat Lalani, Charles Hicks. (2008) Does antiretroviral therapy prevent HIV transmission to sexual partners?. Current Infectious Disease Reports 10:2, 140-145
    CrossRef

  44. 44

    R. F Baggaley, R. G White, M.-C. Boily. (2008) Systematic review of orogenital HIV-1 transmission probabilities. International Journal of Epidemiology 37:6, 1255-1265
    CrossRef

  45. 45

    F. Kapadia, M.H. Latka, S.M. Hudson, E.T. Golub, J.V. Campbell, S. Bailey, V. Frye, R.S. Garfein. (2007) Correlates of consistent condom use with main partners by partnership patterns among young adult male injection drug users from five US cities. Drug and Alcohol Dependence 91, S56-S63
    CrossRef

  46. 46

    Mary H Latka, Yuko Mizuno, YingFeng Wu, Karin E Tobin, Lisa R Metsch, Victoria Frye, Cynthia A Gómez, Julia H Arnsten. (2007) Are Feelings of Responsibility to Limit the Sexual Transmission of HIV Associated With Safer Sex Among HIV-Positive Injection Drug Users?. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:Supplement 2, S88-S95
    CrossRef

  47. 47

    Lynda M. Sagrestano, Amy Rogers, Arron Service. 2007. HIV/AIDS. , 201-228.
    CrossRef

  48. 48

    X. M. Tu, C. Feng, J. Kowalski, W. Tang, H. Wang, C. Wan, Y. Ma. (2007) Correlation analysis for longitudinal data: applications to HIV and psychosocial research. Statistics in Medicine 26:22, 4116-4138
    CrossRef

  49. 49

    IM Poynten, DE Smith, DA Cooper, JM Kaldor, AE Grulich. (2007) The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV. HIV Medicine 8:6, 374-381
    CrossRef

  50. 50

    Louis Bujan, Lital Hollander, Mathieu Coudert, Carole Gilling-Smith, Alexandra Vucetich, Juliette Guibert, Pietro Vernazza, Jeanine Ohl, Michael Weigel, Yvon Englert, Augusto E Semprini. (2007) Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 21:14, 1909-1914
    CrossRef

  51. 51

    O.O. Oguntibeju ., W.M.J. van den Heever ., F.E. Van Schalkwyk .. (2007) A Review of the Epidemiology, Biology and Pathogenesis of HIV. Journal of Biological Sciences 7:8, 1296-1304
    CrossRef

  52. 52

    Jared M Baeten, Sarah Benki, Vrasha Chohan, Ludo Lavreys, R Scott McClelland, Kishorchandra Mandaliya, Jeckoniah O Ndinya-Achola, Walter Jaoko, Julie Overbaugh. (2007) Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 21:13, 1771-1777
    CrossRef

  53. 53

    J. M. Baeten, L. Lavreys, J. Overbaugh. (2007) The Influence of Hormonal Contraceptive Use on HIV-1 Transmission and Disease Progression. Clinical Infectious Diseases 45:3, 360-369
    CrossRef

  54. 54

    Joelle M Brown, Anna Wald, Alan Hubbard, Kittipong Rungruengthanakit, Tsungai Chipato, Sungwal Rugpao, Francis Mmiro, David D Celentano, Robert S Salata, Charles S Morrison, Barbra A Richardson, Nancy S Padian. (2007) Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 21:12, 1515-1523
    CrossRef

  55. 55

    Tahaniyat Lalani, Charles Hicks. (2007) Does antiretroviral therapy prevent HIV transmission to sexual partners?. Current HIV/AIDS Reports 4:2, 80-85
    CrossRef

  56. 56

    Sunit Kumar Singh. (2007) Topical microbicides against HIV spread: what, where and why?. Future Virology 2:3, 219-224
    CrossRef

  57. 57

    Marguerita Lightfoot, Heather Tevendale, W. Scott Comulada, Mary Jane Rotheram-Borus. (2007) Who Benefited from an Efficacious Intervention for Youth Living with HIV: A Moderator Analysis. AIDS and Behavior 11:1, 61-70
    CrossRef

  58. 58

    M. Hasnain, J. A. Levy, E. K. Mensah, J. M. Sinacore. (2007) Association of educational attainment with HIV risk in African American active injection drug users. AIDS Care 19:1, 87-91
    CrossRef

  59. 59

    Marc Bulterys, Dawn Smith, Ann Chao, Harold Jaffe. (2007) Hormonal contraception and incident HIV-1 infection: new insight and continuing challenges. AIDS 21:1, 97-99
    CrossRef

  60. 60

    Charles S Morrison, Barbra A Richardson, Francis Mmiro, Tsungai Chipato, David D Celentano, Joanne Luoto, Roy Mugerwa, Nancy Padian, Sungwal Rugpao, Joelle M Brown, Peter Cornelisse, Robert A Salata. (2007) Hormonal contraception and the risk of HIV acquisition. AIDS 21:1, 85-95
    CrossRef

  61. 61

    Janice M. Irvine. (2006) Emotional scripts of sex panics. Sexuality Research and Social Policy 3:3, 82-94
    CrossRef

  62. 62

    Seth C. Kalichman, Leickness C. Simbayi, Demetria Cain, Charsey Cherry, Sean Jooste. (2006) Coital Bleeding and HIV Risks Among Men and Women in Cape Town, South Africa. Sexually Transmitted Diseases 33:9, 551-557
    CrossRef

  63. 63

    C Gilling-Smith, JDM Nicopoullos, AE Semprini, LCG Frodsham. (2006) HIV and reproductive care—a review of current practice. BJOG: An International Journal of Obstetrics and Gynaecology 113:8, 869-878
    CrossRef

  64. 64

    Viviana Simon, David D Ho, Quarraisha Abdool Karim. (2006) HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. The Lancet 368:9534, 489-504
    CrossRef

  65. 65

    Kabir Sardana, Virendra N. Sehgal. (2006) Genital ulcer disease and human immunodeficiency virus: a focus. International Journal of Dermatology 0:0, 060720080827216
    CrossRef

  66. 66

    Jeny Wegbreit, Stefano Bertozzi, Lisa M DeMaria, Nancy S Padian. (2006) Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS 20:9, 1217-1235
    CrossRef

  67. 67

    Mary H. Latka, Lisa R. Metsch, Yulo Mizuno, Karin Tobin, Sonia Mackenzie, Julia H. Arnsten, Marc N. Gourevitch. (2006) Unprotected Sex Among HIV-Positive Injection Drug-Using Women and Their Serodiscordant Male Partners. JAIDS Journal of Acquired Immune Deficiency Syndromes 42:2, 222-228
    CrossRef

  68. 68

    F. Mazzilli, M. Delfino, N. Imbrogno, J. Elia, F. Dondero. (2006) Survival of Micro-organisms in Cryostorage of Human Sperm. Cell and Tissue Banking 7:2, 75-79
    CrossRef

  69. 69

    J Campo, MA Perea, J del Romero, J Cano, V Hernando, A Bascones. (2006) Oral transmission of HIV, reality or fiction? An update. Oral Diseases 12:3, 219-228
    CrossRef

  70. 70

    Nicoli Nattrass. (2006) What Determines Cross-Country Access to Antiretroviral Treatment?. Development Policy Review 24:3, 321-337
    CrossRef

  71. 71

    Mollie Kane. 2006. Contraceptive Devices. .
    CrossRef

  72. 72

    Esther E Freeman, Helen A Weiss, Judith R Glynn, Pamela L Cross, James A Whitworth, Richard J Hayes. (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:1, 73-83
    CrossRef

  73. 73

    Michel Garenne. (2006) Male Circumcision and HIV Control in Africa. PLoS Medicine 3:1, e78
    CrossRef

  74. 74

    Leigh F. Johnson, Rob Dorrington. (2006) Modelling the demographic impact of HIV/AIDS in South Africa and the likely impact of interventions. Demographic Research 14, 541-574
    CrossRef

  75. 75

    Mary H. Latka, Tracey E. Wilson, Judith A. Cook, Melanie C. Bacon, Jean L. Richardson, Nancy Sohler, Mardge H. Cohen, Ruth M. Greenblatt, Evie Andreopoulis, David Vlahov. (2005) Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women. Journal of Substance Abuse Treatment 29:4, 329-337
    CrossRef

  76. 76

    Gary S. Nakhuda, Joseph E. Pena, Mark V. Sauer. (2005) Deaths of HIV-Positive Men in the Context of Assisted Reproduction: Five Case Studies from a Single Center. AIDS Patient Care and STDs 19:11, 712-718
    CrossRef

  77. 77

    Carlos del Rio. (2005) AIDS: The Second Wave. Archives of Medical Research 36:6, 682-688
    CrossRef

  78. 78

    Phoebe Kajubi, Moses R Kamya, Sarah Kamya, Sanny Chen, Willi McFarland, Norman Hearst. (2005) Increasing Condom Use Without Reducing HIV Risk. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:1, 77-82
    CrossRef

  79. 79

    Jes??s Castilla, Jorge del Romero, Victoria Hernando, Beatriz Marincovich, Soledad Garc??a, Carmen Rodr??guez. (2005) Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:1, 96-101
    CrossRef

  80. 80

    Beatrice “Bean” E. Robinson, Karen Scheltema, Tonya Cherry. (2005) Risky sexual behavior in low‐income African American women: The impact of sexual health variables. Journal of Sex Research 42:3, 224-237
    CrossRef

  81. 81

    D. Hawkins, M. Blott, P. Clayden, A. de Ruiter, G. Foster, C. Gilling-Smith, B. Gosrani, H. Lyall, D. Mercey, M-L. Newell, S. O'Shea, R. Smith, J. Sunderland, C. Wood, G. Taylor, . (2005) Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Medicine 6:S2, 107-148
    CrossRef

  82. 82

    Joseph Sexton, Geoff Garnett, John-Arne R??ttingen. (2005) Metaanalysis and Metaregression in Interpreting Study Variability in the Impact of Sexually Transmitted Diseases on Susceptibility to HIV Infection. Sexually Transmitted Diseases 32:6, 351-357
    CrossRef

  83. 83

    Hirut T. Gebrekristos, Stephen C. Resch, Khangelani Zuma, Mark N. Lurie. (2005) Estimating the Impact of Establishing Family Housing on the Annual Risk of HIV Infection in South African Mining Communities. Sexually Transmitted Diseases 32:6, 333-340
    CrossRef

  84. 84

    Kabir Sardana, Virendra N. Sehgal. (2005) Genital ulcer disease and human immunodeficiency virus: a focus. International Journal of Dermatology 44:5, 391-405
    CrossRef

  85. 85

    Emily Oster. (2005) Sexually Transmitted Infections, Sexual Behavior, and The HIV/AIDS Epidemic*. Quarterly Journal of Economics 120:2, 467-515
    CrossRef

  86. 86

    Jeffrey T Parsons, Eric W Schrimshaw, Richard J Wolitski, Perry N Halkitis, David W Purcell, Colleen C Hoff, Cynthia A Gómez. (2005) Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS 19:Supplement 1, S13-S25
    CrossRef

  87. 87

    Sanders, Gillian D., Bayoumi, Ahmed M., Sundaram, Vandana, Bilir, S. Pinar, Neukermans, Christopher P., Rydzak, Chara E., Douglass, Lena R., Lazzeroni, Laura C., Holodniy, Mark, Owens, Douglas K., . (2005) Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy. New England Journal of Medicine 352:6, 570-585
    Full Text

  88. 88

    Michelle Giles, Anne Mijch, Suzanne Garland. (2005) Assisted reproduction for HIV-infected couples. Sexual Health 2:4, 223
    CrossRef

  89. 89

    Richard G White, Kate K Orroth, Eline L Korenromp, Roel Bakker, Mwita Wambura, Nelson K Sewankambo, Ron H Gray, Anatoli Kamali, James A. G Whitworth, Heiner Grosskurth, J Dik F Habbema, Richard J Hayes. (2004) Can Population Differences Explain the Contrasting Results of the Mwanza, Rakai, and Masaka HIV/Sexually Transmitted Disease Intervention Trials?. JAIDS Journal of Acquired Immune Deficiency Syndromes 37:4, 1500-1513
    CrossRef

  90. 90

    Susan S. Witte, Nabila El-Bassel, Louisa Gilbert, Elwin Wu, Mingway Chang, Peter Steinglass. (2004) Recruitment of Minority Women and Their Main Sexual Partners in an HIV/STI Prevention Trial. Journal of Women's Health 13:10, 1137-1147
    CrossRef

  91. 91

    Lut Van Damme. (2004) Clinical microbicide research: an overview. Tropical Medicine and International Health 9:12, 1290-1296
    CrossRef

  92. 92

    Stephen J. Genuis, Shelagh K. Genuis. (2004) Managing the sexually transmitted disease pandemic: A time for reevaluation. American Journal of Obstetrics and Gynecology 191:4, 1103-1112
    CrossRef

  93. 93

    Esther E Freeman, Judith R Glynn. (2004) Factors affecting HIV concordancy in married couples in four African cities. AIDS 18:12, 1715-1721
    CrossRef

  94. 94

    P. Heather Lyttle, Sandra C. Thompson. (2004) Maintaining sexual health in commercial sex workers in Australia: condom effectiveness, screening, and management after acquiring sexually transmissible infections. Australian and New Zealand Journal of Public Health 28:4, 351-359
    CrossRef

  95. 95

    Cheryl-Ann Monteiro, Laura H. Bachmann, Renee A. Desmond, Kathleen E. Squires, Sten H. Vermund, Edward W. Hook, Jane R. Schwebke, Craig J. Hoesley. (2004) Incidence and Risk Factors for Sexually Transmitted Infections among Women in an Alabama HIV Clinic. AIDS Research and Human Retroviruses 20:6, 577-583
    CrossRef

  96. 96

    Isabelle Heard, Val??rie Potard, Dominique Costagliola, Michel D. Kazatchkine. (2004) Contraceptive Use in HIV-Positive Women. JAIDS Journal of Acquired Immune Deficiency Syndromes 36:2, 714-720
    CrossRef

  97. 97

    Richard Steen, Gina Dallabetta. (2004) Genital ulcer disease control and HIV prevention. Journal of Clinical Virology 29:3, 143-151
    CrossRef

  98. 98

    David D. Celentano. (2004) Editorial Response: It’s All in the Measurement: Consistent Condom Use Is Effective in Preventing Sexually Transmitted Infections. Sexually Transmitted Diseases 31:3, 161
    CrossRef

  99. 99

    Kate Dolan, David Lowe, James Shearer. (2004) Evaluation of the condom Distribution Program in New South Wales Prisons, Australia. The Journal of Law, Medicine & Ethics 32:1, 124-128
    CrossRef

  100. 100

    Judith C. Shlay, Melissa W. McClung, Jennifer L. Patnaik, John M. Douglas. (2004) Comparison of Sexually Transmitted Disease Prevalence by Reported Level of Condom Use Among Patients Attending an Urban Sexually Transmitted Disease Clinic. Sexually Transmitted Diseases 31:3, 154-160
    CrossRef

  101. 101

    , , , , . (2004) Recommendations for Incorporating Human Immunodeficiency Virus (HIV) Prevention into the Medical Care of Persons Living with HIV. Clinical Infectious Diseases 38:1, 104-121
    CrossRef

  102. 102

    H CEJTIN. (2003) Gynecologic issues in the HIV-infected woman. Obstetrics and Gynecology Clinics of North America 30:4, 711-729
    CrossRef

  103. 103

    Mark N Lurie, Brian G Williams, Khangelani Zuma, David Mkaya-Mwamburi, Geoff P Garnett, Michael D Sweat, Joel Gittelsohn, Salim SAbdool Karim. (2003) Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS 17:15, 2245-2252
    CrossRef

  104. 104

    Molina B. Dayal, James Wheeler, Carmen J. Williams, Kurt T. Barnhart. (2003) Disruption of the upper female reproductive tract epithelium by nonoxynol-9. Contraception 68:4, 273-279
    CrossRef

  105. 105

    Robin J. Shattock, John P. Moore. (2003) Inhibiting sexual transmission of HIV-1 infection. Nature Reviews Microbiology 1:1, 25-34
    CrossRef

  106. 106

    Judith R. Glynn, Michel Caraël, Anne Buvé, Rosemary M. Musonda, Maina Kahindo. (2003) HIV Risk in Relation to Marriage in Areas With High Prevalence of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 33:4, 526-535
    CrossRef

  107. 107

    R. A. Crosby, R. J. DiClemente, G. M. Wingood, D. Lang, K. F. Harrington. (2003) Value of Consistent Condom Use: A Study of Sexually Transmitted Disease Prevention Among African American Adolescent Females. American Journal of Public Health 93:6, 901-902
    CrossRef

  108. 108

    N. El-Bassel, S. S. Witte, L. Gilbert, E. Wu, M. Chang, J. Hill, P. Steinglass. (2003) The Efficacy of a Relationship-Based HIV/STD Prevention Program for Heterosexual Couples. American Journal of Public Health 93:6, 963-969
    CrossRef

  109. 109

    Theresa Hatzell, Paul J. Feldblum, Rick K. Homan, Rebecca D. Gmach. (2003) The Female Condom: Is ???Just as Good??? Good Enough?. Sexually Transmitted Diseases 30:5, 440-442
    CrossRef

  110. 110

    Maria Xiridou, Ronald Geskus, John de Wit, Roel Coutinho, Mirjam Kretzschmar. (2003) The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS 17:7, 1029-1038
    CrossRef

  111. 111

    Susan Allen, Jareen Meinzen-Derr, Michele Kautzman, Isaac Zulu, Stanley Trask, Ulgen Fideli, Rosemary Musonda, Francis Kasolo, Feng Gao, Alan Haworth. (2003) Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 17:5, 733-740
    CrossRef

  112. 112

    Carl A Latkin, Valerie Forman, Amy Knowlton, Susan Sherman. (2003) Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Social Science & Medicine 56:3, 465-476
    CrossRef

  113. 113

    Nicholas C Grassly, Catherine M Lowndes, Tim Rhodes, Ali Judd, Adrian Renton, Geoffrey P Garnett. (2003) Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India. International Journal of Drug Policy 14:1, 25-43
    CrossRef

  114. 114

    H. Letur-Konirsch. (2003) Safety of cryopreservation straws for human gametes or embryos: a study with human immunodeficiency virus-1 under cryopreservation conditions. Human Reproduction 18:1, 140-144
    CrossRef

  115. 115

    J. THOMAS FITCH, CURTIS STINE, W. DAVID HAGER, JOSHUA MANN, MARY B. ADAM, JOE MCILHANEY. (2002) Condom Effectiveness. Sexually Transmitted Diseases 29:12, 811-817
    CrossRef

  116. 116

    J. Pulerwitz, H. Amaro, W. De Jong, S. L. Gortmaker, R. Rudd. (2002) Relationship power, condom use and HIV risk among women in the USA. AIDS Care 14:6, 789-800
    CrossRef

  117. 117

    LISA E. MANHART, LAURA A. KOUTSKY. (2002) Do Condoms Prevent Genital HPV Infection, External Genital Warts, or Cervical Neoplasia?. Sexually Transmitted Diseases 29:11, 725-735
    CrossRef

  118. 118

    A. D. Forsyth, T. J. Coates, O. A. Grinstead, G. Sangiwa, D. Balmer, M. C. Kamenga, S. E. Gregorich. (2002) HIV Infection and Pregnancy Status Among Adults Attending Voluntary Counseling and Testing in 2 Developing Countries. American Journal of Public Health 92:11, 1795-1800
    CrossRef

  119. 119

    SEVGI O. ARAL, THOMAS A. PETERMAN. (2002) A Stratified Approach to Untangling the Behavioral/Biomedical Outcomes Conundrum. Sexually Transmitted Diseases 29:9, 530-532
    CrossRef

  120. 120

    Jorge del Romero, Beatriz Marincovich, Jesús Castilla, Soledad García, Julián Campo, Victoria Hernando, Carmen Rodríguez. (2002) Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16:9, 1296-1297
    CrossRef

  121. 121

    J. O. O. Oyesiku, C. F. Turner. (2002) Reproductive choices for couples with haemophilia. Haemophilia 8:3, 348-352
    CrossRef

  122. 122

    Stéphane Hugonnet, Frank Mosha, James Todd, Kokugonza Mugeye, Arnoud Klokke, Leonard Ndeki, David Ross, Heiner Grosskurth, Richard Hayes. (2002) Incidence of HIV Infection in Stable Sexual Partnerships: A Retrospective Cohort Study of 1802 Couples in Mwanza Region, Tanzania. JAIDS Journal of Acquired Immune Deficiency Syndromes 30:1, 73-80
    CrossRef

  123. 123

    Sodsai Tovanabutra, Valerie Robison, Jeerang Wongtrakul, Supaluk Sennum, Vinai Suriyanon, Duangnapa Kingkeow, Surinda Kawichai, Praijitr Tanan, Ann Duerr, Kenrad E. Nelson. (2002) Male Viral Load and Heterosexual Transmission of HIV-1 Subtype E in Northern Thailand. JAIDS Journal of Acquired Immune Deficiency Syndromes 29:3, 275-283
    CrossRef

  124. 124

    Hong-Ha M. Truong, M. Michelle Berrey, Theresa Shea, Kurt Diem, Lawrence Corey. (2002) Concordance Between HIV Source Partner Identification and Molecular Confirmation in Acute Retroviral Syndrome. JAIDS Journal of Acquired Immune Deficiency Syndromes 29:3, 232-243
    CrossRef

  125. 125

    Susan C Weller, Karen Davis-Beaty, Susan C Weller. 2002. Condom effectiveness in reducing heterosexual HIV transmission. .
    CrossRef

  126. 126

    Deborah M. Capaldi, Mike Stoolmiller, Sara Clark, Lee D. Owen. (2002) Heterosexual risk behaviors in at-risk young men from early adolescence to young adulthood: Prevalence, prediction, and association with STD contraction.. Developmental Psychology 38:3, 394-406
    CrossRef

  127. 127

    S. Tariq Sadiq, Stephen Taylor, Steve Kaye, Julie Bennett, Ruth Johnstone, Patrick Byrne, Andrew J. Copas, Susan M. Drake, Deenan Pillay, Ian Weller. (2002) The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS 16:2, 219-225
    CrossRef

  128. 128

    BEENA VARGHESE, JULIE E. MAHER, THOMAS A. PETERMAN, BERNARD M. BRANSON, RICHARD W. STEKETEE. (2002) Reducing the Risk of Sexual HIV Transmission. Sexually Transmitted Diseases 29:1, 38-43
    CrossRef

  129. 129

    Thomas M Painter. (2001) Voluntary counseling and testing for couples: a high-leverage intervention for HIV/AIDS prevention in sub-Saharan Africa. Social Science & Medicine 53:11, 1397-1411
    CrossRef

  130. 130

    Kate Buchacz, Ariane van der Straten, Janet Saul, Stephen C. Shiboski, Cynthia A. Gomez, Nancy Padian. (2001) Sociodemographic, Behavioral, and Clinical Correlates of Inconsistent Condom Use in HIV-Serodiscordant Heterosexual Couples. JAIDS Journal of Acquired Immune Deficiency Syndromes 28:3, 289-297
    CrossRef

  131. 131

    Saifuddin Ahmed, Tom Lutalo, Maria Wawer, David Serwadda, Nelson K. Sewankambo, Fred Nalugoda, Fred Makumbi, Fred Wabwire-Mangen, Noah Kiwanuka, Godfrey Kigozi, Mohamed Kiddugavu, Ron Gray. (2001) HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS 15:16, 2171-2179
    CrossRef

  132. 132

    SUPANEE JIVASAK-APIMAS, JOSEPH SABA, VERAPOL CHANDEYING, CHUANCHOM SAKONDHAVAT, ORAWAN KIRIWAT, SUNGWAL RUGPAO, WIWAT ROJANAPITHAYAKORN, ARNAUD L. FONTANET. (2001) Acceptability of the Female Condom Among Sex Workers in Thailand. Sexually Transmitted Diseases 28:11, 648-654
    CrossRef

  133. 133

    ELINE L. KORENROMP, SAKE J. de VLAS, NICO J. D. NAGELKERKE, J. DIK F. HABBEMA. (2001) Estimating the Magnitude of STD Cofactor Effects on HIV Transmission. Sexually Transmitted Diseases 28:11, 613-621
    CrossRef

  134. 134

    JOHN-ARNE R??TTINGEN, D. WILLIAM CAMERON, GEOFFREY P. GARNETT. (2001) A Systematic Review of the Epidemiologic Interactions Between Classic Sexually Transmitted Diseases and HIV. Sexually Transmitted Diseases 28:10, 579-597
    CrossRef

  135. 135

    Richard Crosby, Ralph J DiClemente, Gina M Wingood, Catlainn Sionean, Brenda K Cobb, Kathy Harrington, Susan Davies, Edward W Hook, M.Kim Oh. (2001) Correct condom application among African-American adolescent females: the relationship to perceived self-efficacy and the association to confirmed STDs. Journal of Adolescent Health 29:3, 194-199
    CrossRef

  136. 136

    J. R. Glynn, M. Caraël, B. Auvert, M. Kahindo, J. Chege, R. Musonda, F. Kaona, A. Buvé. (2001) Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 15, S51-S60
    CrossRef

  137. 137

    Michelle B. Orner, Thera Meehan, Daniel R. Brooks, Lorelei A. Mucci, Jean F. McGuire. (2001) Support for Condom Availability and Needle Exchange Programs Among Massachusetts Adults, 1997. AIDS Education and Prevention 13:4, 365-376
    CrossRef

  138. 138

    Diane E. Elze, Wendy Auslander, Curtis McMillen, Tonya Edmond, Ron Thompson. (2001) Untangling the Impact of Sexual Abuse on HIV Risk Behaviors Among Youths in Foster Care. AIDS Education and Prevention 13:4, 377-389
    CrossRef

  139. 139

    Ülgen Semaye Fideli, Susan A. Allen, Rosemary Musonda, Stan Trask, Beatrice H. Hahn, Heidi Weiss, Joseph Mulenga, Francis Kasolo, Sten H. Vermund, Grace M. Aldrovandi. (2001) Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa. AIDS Research and Human Retroviruses 17:10, 901-910
    CrossRef

  140. 140

    Emmanuel Lagarde, Michel Caraël, Judith R. Glynn, Lydie Kanhonou, Séverin-Cécile Abega, Maina Kahindo, Rosemary Musonda, Bertran Auvert, Anne Buvé. (2001) Educational level is associated with condom use within non-spousal partnerships in four cities of sub-Saharan Africa. AIDS 15:11, 1399-1408
    CrossRef

  141. 141

    Pietro L. Vernazza, Angela D. M. Kashuba, Myron S. Cohen. (2001) Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health. Reviews in Medical Microbiology 12:3, 131-142
    CrossRef

  142. 142

    S. R. Friedman, P. L. Flom, B. J. Kottiri, A. Neaigus, M. Sandoval, R. Curtis, D. C. Des Jarlais, J. M. Zenilman. (2001) Consistent condom use in the heterosexual relationships of young adults who live in a high-HIV-risk neighbourhood and do not use "hard drugs". AIDS Care 13:3, 285-296
    CrossRef

  143. 143

    R Klevens. (2001) Knowledge of partner risk and secondary transmission of HIV. American Journal of Preventive Medicine 20:4, 277-281
    CrossRef

  144. 144

    Ronald H Gray, Maria J Wawer, Ron Brookmeyer, Nelson K Sewankambo, David Serwadda, Fred Wabwire-Mangen, Tom Lutalo, Xianbin Li, Thomas vanCott, Thomas C Quinn. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. The Lancet 357:9263, 1149-1153
    CrossRef

  145. 145

    Landon Myer, Catherine Mathews, Francesca Little, Salim S. Abdool Karim. (2001) The fate of free male condoms distributed to the public in South Africa. AIDS 15:6, 789-793
    CrossRef

  146. 146

    Maureen Miller, Alan Neaigus. (2001) Networks, resources and risk among women who use drugs. Social Science & Medicine 52:6, 967-978
    CrossRef

  147. 147

    Farhad B. Hashemi, Juergen Mollenhauer, Lawrence D. Madsen, Beverly E. Sha, Wolfgang Nacken, Mary B. Moyer, Clemens Sorg, Gregory T. Spear. (2001) Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication. AIDS 15:4, 441-449
    CrossRef

  148. 148

    William W. Darrow. (2001) Latex condoms, human behavior, and public health. AIDS 15:2, 267-269
    CrossRef

  149. 149

    Martin Fishbein, Blair Jarvis. (2000) Failure to Find a Behavioral Surrogate for STD Incidence - What Does It Really Mean?. Sexually Transmitted Diseases 27:8, 452-455
    CrossRef

  150. 150

    Thomas A. Peterman, Lillian S. Lin, Daniel R. Newman, Mary L. Kamb, Gail Bolan, Jonathan Zenilman, John M. Douglas, Judy Rogers, C. Kevin Malotte. (2000) Does Measured Behavior Reflect STD Risk?. Sexually Transmitted Diseases 27:8, 446-451
    CrossRef

  151. 151

    Mary Latka, Erica Gollub, Pamela French, Zena Stein. (2000) Male-Condom and Female-Condom Use Among Women After Counseling in a Risk-Reduction Hierarchy for STD Prevention. Sexually Transmitted Diseases 27:8, 431-437
    CrossRef

  152. 152

    Eline L. Korenromp, Carina van Vliet, Roel Bakker, Sake J. de Vlas, J. Dik F. Habbema. (2000) HIV spread and partnership reduction for different patterns of sexual behaviour ‐ a study with the microsimulation model STDSIM. Mathematical Population Studies 8:2, 135-173
    CrossRef

  153. 153

    Emma Gilmour, Salim S. Abdool Karim, Helena J. Fourie. (2000) Availability of Condoms in Urban and Rural Areas of KwaZulu-Natal, South Africa. Sexually Transmitted Diseases 27:6, 353-357
    CrossRef

  154. 154

    Hideji Hanabusa, Naoaki Kuji, Shingo Kato, Hisamichi Tagami, Satoru Kaneko, Hiroaki Tanaka, Yasunori Yoshimura. (2000) An evaluation of semen processing methods for eliminating HIV-1. AIDS 14:11, 1611-1616
    CrossRef

  155. 155

    G. S. Zaric, P. G. Barnett, M. L. Brandeau. (2000) HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 90:7, 1100-1111
    CrossRef

  156. 156

    Matthias Egger, Josefina Pauw, Athanasios Lopatatzidis, Danilo Medrano, Fred Paccaud, George Davey Smith. (2000) Promotion of condom use in a high-risk setting in Nicaragua: a randomised controlled trial. The Lancet 355:9221, 2101-2105
    CrossRef

  157. 157

    Carol Tévi-Bénissan, Maria Makuva, Audrey Morelli, Marie-Claude Georges-Courbot, Mathieu Matta, Alain Georges, Laurent Bélec. (2000) Protection of Cynomolgus Macaque Against Cervicovaginal Transmission of SIVmac251 by the Spermicide Benzalkonium Chloride. Journal of Acquired Immune Deficiency Syndromes 24:2, 147-153
    CrossRef

  158. 158

    Carol Tévi-Bénissan, Maria Makuva, Audrey Morelli, Marie-Claude Georges-Courbot, Mathieu Matta, Alain Georges, Laurent Bélec. (2000) Protection of Cynomolgus Macaque Against Cervicovaginal Transmission of SIVmac251 by the Spermicide Benzalkonium Chloride. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:2, 147-153
    CrossRef

  159. 159

    Karen Rotchford, Willem A. Strum, David Wilkinson. (2000) Effect of Coinfection With STDs and of STD Treatment on HIV Shedding in Genital-Tract Secretions. Sexually Transmitted Diseases 27:5, 243-248
    CrossRef

  160. 160

    Quinn, Thomas C., Wawer, Maria J., Sewankambo, Nelson, Serwadda, David, Li, Chuanjun, Wabwire-Mangen, Fred, Meehan, Mary O., Lutalo, Thomas, Gray, Ronald H., . (2000) Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1. New England Journal of Medicine 342:13, 921-929
    Full Text

  161. 161

    Maurizio Macaluso, Michael J. Demand, Lynn M. Artz, Edward W. Hook. (2000) Partner type and condom use. AIDS 14:5, 537-546
    CrossRef

  162. 162

    Eline L. Korenromp, Carina Van Vliet, Heiner Grosskurth, Awene Gavyole, Catharina PB Van der Ploeg, Lieve Fransen, Richard J. Hayes, J. Dik F. Habbema. (2000) Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS 14:5, 573-593
    CrossRef

  163. 163

    C. Scully, S. Porter. (2000) HIV topic update: oro-genital transmission of HIV. Oral Diseases 6:2, 92-98
    CrossRef

  164. 164

    J. L. Lauby, P. J. Smith, M. Stark, B. Person, J. Adams. (2000) A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. American Journal of Public Health 90:2, 216-222
    CrossRef

  165. 165

    Donald B. Louria, Joan H. Skurnick, Paul Palumbo, John D. Bogden, Christine Rohowsky-Kochan, Thomas N. Denny, Cheryl A. Kennedy. (2000) HIV heterosexual transmission: A hypothesis about an additional potential determinant. International Journal of Infectious Diseases 4:2, 110-116
    CrossRef

  166. 166

    Cathy W. Critchlow, Nancy B. Kiviat. (1999) Detection of Human Immunodeficiency Virus Type 1 and Type 2 in the Female Genital Tract: Implications for the Understanding of Virus Transmission. Obstetrical & Gynecological Survey 54:Supplement, 187-196
    CrossRef

  167. 167

    Markus J. Steiner, Willard Cates, Lee Warner. (1999) The Real Problem with Male Condoms Is Nonuse. Sexually Transmitted Diseases 26:8, 459-462
    CrossRef

  168. 168

    Beena Varghese, Thomas A. Peterman, David R. Holtgrave. (1999) Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS 13:13, 1745-1751
    CrossRef

  169. 169

    Michael E. Jones. (1999) HIV and the Returning Expatriate. Journal of Travel Medicine 6:2, 99-106
    CrossRef

  170. 170

    Anne Tachet, Emmanuel Dulioust, Dominique Salmon, Marta De Almeida, Sylvie Rivalland, Laurent Finkielsztejn, Isabelle Heard, Pierre Jouannet, Didier Sicard, Christine Rouzioux. (1999) Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 13:7, 823-831
    CrossRef

  171. 171

    Joel Rakwar, Ludo Lavreys, Mary Lou Thompson, Denis Jackson, Job Bwayo, Salim Hassanali, Kishorchandra Mandaliya, Jeckoniah Ndinya-Achola, Joan Kreiss. (1999) Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya. AIDS 13:5, 607-614
    CrossRef

  172. 172

    Gilles Delage, Claire Infante–Rivard, Jo–Anne Chiavetta, Bernard Willems, David Pi, Margaret Fast. (1999) Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study. Gastroenterology 116:4, 893-899
    CrossRef

  173. 173

    Maurizio Macaluso, Lynn Artz, Joseph Kelaghan, Harland Austin, Michael Fleenor, Edward W. Hook. (1999) Prospective Study of Barrier Contraception for the Prevention of Sexually Transmitted Diseases. Sexually Transmitted Diseases 26:3, 127-136
    CrossRef

  174. 174

    M. MILLER. (1999) A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care 11:1, 3-20
    CrossRef

  175. 175

    JAMES G. DOBBINS, TIMOTHY D. MASTRO, TAWEESAK NOPKESORN, SUEBPONG SANGKHAROMYA, KHANCHIT LIMPAKARNJANARAT, BRUCE G. WENIGER, D. SCOTT SCHMID. (1999) Herpes in the Time of AIDS: A Comparison of the Epidemiology of HIV-1 and HSV-2 in Young Men in Northern Thailand. Sexually Transmitted Diseases 26:2, 67-74
    CrossRef

  176. 176

    Pietro L. Vernazza, Joseph J. Eron, Susan A. Fiscus, Myron S. Cohen. (1999) Sexual transmission of HIV: infectiousness and prevention. AIDS 13:2, 155-166
    CrossRef

  177. 177

    Harry W. Haverkos. (1998) HIV/AIDS and Drug Abuse: Epidemiology and Prevention. Journal of Addictive Diseases 17:4, 91-103
    CrossRef

  178. 178

    Richard B. Rothenberg, Margaret Scarlett, Carlos del Rio, David Reznik, Christine OʼDaniels. (1998) Oral transmission of HIV. AIDS 12:16, 2095-2105
    CrossRef

  179. 179

    Michael Bloor, Michelle Thomas, Kerenza Hood, Damiano Abeni, Catherine Goujon, Dominique Hausser, Michel Hubert, Dieter Kleiber, Jose Antonio Nieto. (1998) Differences in sexual risk behaviour between young men and women travelling abroad from the UK. The Lancet 352:9141, 1664-1668
    CrossRef

  180. 180

    Christiana Coggins, Sheldon Segal. (1998) AIDS and reproductive health. Journal of Reproductive Immunology 41:1-2, 3-15
    CrossRef

  181. 181

    Arnaud L Fontanet, Joseph Saba, Verapol Chandelying, Chuanchom Sakondhavat, Praphas Bhiraleus, Sungwal Rugpao, Chompilas Chongsomchai, Orawan Kiriwat, Sodsai Tovanabutra, Leonard Dally, Joep M Lange, Wiwat Rojanapithayakorn. (1998) Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom. AIDS 12:14, 1851-1859
    CrossRef

  182. 182

    Peter H. Kilmarx, Khanchit Limpakarnjanarat, Timothy D. Mastro, Supachai Saisorn, Jaranit Kaewkungwal, Supaporn Korattana, Wat Uthaivoravit, Nancy L. Young, Bruce G. Weniger, Michael E. St Louis. (1998) HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand. AIDS 12:14, 1889-1898
    CrossRef

  183. 183

    LEE WARNER, JODY CLAY-WARNER, JACQUELINE BOLES, JOHN WILLIAMSON. (1998) Assessing Condom Use Practices. Sexually Transmitted Diseases 25:6, 273-277
    CrossRef

  184. 184

    Myron S. Cohen, William C. Miller. (1998) Sexually transmitted diseases and human immunodeficiency virus infection: Cause, effect, or both?. International Journal of Infectious Diseases 3:1, 1-4
    CrossRef

  185. 185

    Frank Johnstone, David Goldberg, David Tappin, Lindsay Mathie, Sheila Cameron, Ariene Brown, Sheila Burns, Barbara Hamilton, Glen Codere, R W. Anthony Girdwood. (1998) The incidence and prevalence of HIV infection among childbearing women living in Edinburgh city, 1982–1995. AIDS 12:8, 911-918
    CrossRef

  186. 186

    Thomas N. Denny, Joan H. Skurnick, Paul Palumbo, George Perez, Raymond Monel, Richard Stephens, Cheryl A. Kennedy, Donald B. Louria. (1998) CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: A report from the heterosexual HIV transmission study. International Journal of Infectious Diseases 2:4, 186-192
    CrossRef

  187. 187

    E Susser, M Desvarieux, K M Wittkowski. (1998) Reporting sexual risk behavior for HIV: a practical risk index and a method for improving risk indices.. American Journal of Public Health 88:4, 671-674
    CrossRef

  188. 188

    A Spruyt, M J Steiner, C Joanis, L H Glover, C Piedrahita, G Alvarado, R Ramos, C Maglaya, M Cordero. (1998) Identifying condom users at risk for breakage and slippage: findings from three international sites.. American Journal of Public Health 88:2, 239-244
    CrossRef

  189. 189

    Daniel W. Fitzgerald, Frieda M.-T. Behets, Catherine Lucet, Dominique Roberfroid. (1998) Prevalence, burden, and control of syphilis in Haiti's rural artibonite region. International Journal of Infectious Diseases 2:3, 127-131
    CrossRef

  190. 190

    Howard Minkoff, Ira Ehrlich, Joseph Feldman, Susan Holman, Serena Fazili, Michael Augenbraun. (1998) Reproductive health hospitalizations among women with human immunodeficiency virus infections. American Journal of Obstetrics and Gynecology 178:1, 166-170
    CrossRef

  191. 191

    D LYNCH. (1997) Oral manifestations of HIV disease: An update. Seminars in Cutaneous Medicine and Surgery 16:4, 257-264
    CrossRef

  192. 192

    M FOWLER. (1997) WOMEN AND HIVEpidemiology and Global Overview. Obstetrics and Gynecology Clinics of North America 24:4, 705-729
    CrossRef

  193. 193

    Tippavan Nagachinta, Ann Duerr, Vinai Suriyanon, Niwes Nantachit, Sungwal Rugpao, Chanane Wanapirak, Jatupol Srisomboon, Nuonchuen Kamtorn, Sodsai Tovanabutra, Yuttana Mundee, Yupadee Yutrabutr, Rassamee Kaewvichit, Kittipong Rungruengthanakit, Melanie de Boer, Antika Tansuhaj, Lisa Flowers, Chirasak Khamboonruang, David D. Celentano, Kenrad E. Nelson. (1997) Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand. AIDS 11:14, 1765-1772
    CrossRef

  194. 194

    Kevin A. Fenton, Thomas A. Peterman. (1997) HIV partner notification. AIDS 11:13, 1535-1546
    CrossRef

  195. 195

    MARCIA L. SHEW, GARY J. REMAFEDI, LINDA H. BEARINGER, PATRICIA L. FAULKNER, BARBARA A. TAYLOR, SANDRA J. POTTHOFF, MICHAEL D. RESNICK. (1997) The Validity of Self-Reported Condom Use Among Adolescents. Sexually Transmitted Diseases 24:9, 503-510
    CrossRef

  196. 196

    Pietro L. Vernazza, Bruce L. Gilliam, Markus Flepp, John R. Dyer, Andreas C. Frank, Susan A. Fiscus, Myron S. Cohen, Joseph J. Eron. (1997) Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 11:10, 1249-1254
    CrossRef

  197. 197

    Nicola Gavey, Kathryn McPhillips. (1997) Women and the Heterosexual Transmission of HIV: Risks and Prevention Strategies. Women & Health 25:2, 41-64
    CrossRef

  198. 198

    Pietro L. Vernazza, Bruce L. Gilliam, John Dyer, Susan A. Fiscus, Joseph J. Eron, Andreas C. Frank, Myron S. Cohen. (1997) Quantification of HIV in semen. AIDS 11:8, 987-993
    CrossRef

  199. 199

    ANN K. SULLIVAN, MARK C. ATKINS, FIONA BOAG. (1997) Factors Facilitating the Sexual Transmission of HIV-1. AIDS Patient Care and STDs 11:3, 167-177
    CrossRef

  200. 200

    Angusto E Semprini, Simona Fiore, Gioigio Pardi. (1997) Reproductive counselling for HIV-discordant couples. The Lancet 349:9062, 1401-1402
    CrossRef

  201. 201

    Cathy W. Critchlow, Nancy B. Kiviat. (1997) Detection of Human Immunodeficiency Virus Type 1 and Type 2 in the Female Genital Tract. Obstetrical & Gynecological Survey 52:5, 315-324
    CrossRef

  202. 202

    Steven D. Pinkerton, Paul R. Abramson. (1997) Effectiveness of condoms in preventing HIV transmission. Social Science & Medicine 44:9, 1303-1312
    CrossRef

  203. 203

    Royce, Rachel A., Seña, Arlene, Cates, Willard Jr., Cohen, Myron S., . (1997) Sexual Transmission of HIV. New England Journal of Medicine 336:15, 1072-1078
    Full Text

  204. 204

    SETH C. KALICHMAN, L. YVONNE STEVENSON. (1997) Psychological and Social Factors Associated with Histories of Risk for Human Immunodeficiency Virus Infection Among African-American Inner-City Women. Journal of Women's Health 6:2, 209-217
    CrossRef

  205. 205

    Mary Jane Rotheram-Borus, J. Roy Gillis, Helen M. Reid, M. Isabel Fernandez, Marya Gwadz. (1997) HIV testing, behaviors, and knowledge among adolescents at high risk. Journal of Adolescent Health 20:3, 216-225
    CrossRef

  206. 206

    L Mandelbrot, I Heard, E Henrion-Géant, R Henrion. (1997) Natural conception in HIV-negative women with HIV-infected partners. The Lancet 349:9055, 850-851
    CrossRef

  207. 207

    (1997) Endpoints and other measures in the NIMH Multisite HIV Prevention Trial. AIDS, Supplement 11:Supplement 2, S37???S47
    CrossRef

  208. 208

    Sungwal Rugpao, Chris Beyrer, Sodsai Tovanabutra, Chawalit Natpratan, Kenrad E. Nelson, David D. Celentano, Chirasak Khamboonruang. (1997) Multiple Condom Use and Decreased Condom Breakage and Slippage in Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14:2, 169-173
    CrossRef

  209. 209

    BARBARA G. SILVERMAN, THOMAS P. GROSS. (1997) Use and Effectiveness of Condoms During Anal Intercourse. Sexually Transmitted Diseases 24:1, 11-17
    CrossRef

  210. 210

    Sylvia W. Wright, Richard A. Johnson. (1997) Human immunodeficiency virus in women: Mucocutaneous manifestations. Clinics in Dermatology 15:1, 93-111
    CrossRef

  211. 211

    Patricia Kissinger, Rebecca Clark, Jeanne Dumestre, Ruth Bessinger. (1996) Incidence of three sexually transmitted diseases during a safer sex promotion program for HIV-infected women. Journal of General Internal Medicine 11:12, 750-752
    CrossRef

  212. 212

    William Gardner, Karleen Preator. (1996) Children of Seropositive Mothers in the U.S. AIDS Epidemic. Journal of Social Issues 52:3, 177-195
    CrossRef

  213. 213

    Nelson, Kenrad E., Celentano, David D., Eiumtrakol, Sakol, Hoover, Donald R., Beyrer, Chris, Suprasert, Somboon, Kuntolbutra, Surinda, Khamboonruang, Chirasak, . (1996) Changes in Sexual Behavior and a Decline in HIV Infection among Young Men in Thailand. New England Journal of Medicine 335:5, 297-303
    Full Text

  214. 214

    Tzong-Hae Lee, Nancy Sakahara, Eberhard Fiebig, Michael P. Busch, Thomas R. O'Brien, Steven A. Herman. (1996) Correlation of HIV-1 RNA Levels in Plasma and Heterosexual Transmission of HIV-1 from Infected Transfusion Recipients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12:4, 427
    CrossRef

  215. 215

    S Krishnan, J E Koehler, R Benjamin, A L Reingold. (1996) Reducing delays in the laboratory diagnosis of tuberculosis.. American Journal of Public Health 86:8 Pt 1, 1171-1172
    CrossRef

  216. 216

    S Brody. (1996) Questioning the validity of self-reported heterosexual HIV transmission.. American Journal of Public Health 86:8 Pt 1, 1172-1172
    CrossRef

  217. 217

    D. Serraino, S. Franceschi, L. D. Maso, G. Rezza. (1996) Serraino and Colleagues Respond. American Journal of Public Health 86:8 Pt 1, 1172-1172
    CrossRef

  218. 218

    HARRIET A. WILLIAMS, CATHY E. WATKINS, JOANNE A. RISBY. (1996) Reproductive Decision-Making and Determinants of Contraceptive Use in HIV-Infected Women. Clinical Obstetrics and Gynecology 39:2, 333-343
    CrossRef

  219. 219

    Stuart Brody. (1996) Continued lack of evidence for transmission of human immunodeficiency virus through vaginal intercourse: A reply to Carey and Kalichman. Archives of Sexual Behavior 25:3, 329-337
    CrossRef

  220. 220

    MichaelH. Merson. (1996) Returning home: reflections on the USA's response to the HIV/AIDS epidemic. The Lancet 347:9016, 1673-1676
    CrossRef

  221. 221

    DAVID WYATT SEAL, DEBORAH A. PALMER-SEAL. (1996) Barriers to Condom Use and Safer Sex Talk among College Dating Couples. Journal of Community & Applied Social Psychology 6:1, 15-33
    CrossRef

  222. 222

    Angela M. Downs, Isabelle De Vincenzi. (1996) Probability of Heterosexual Transmission of HIV: Relationship to the Number of Unprotected Sexual Contacts. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11:4, 388-395
    CrossRef

  223. 223

    David Mertz. (1996) Sex Wars: The New Left's AIDS-Related Scientism. Rethinking Marxism 9:1, 134-143
    CrossRef

  224. 224

    Penelope J. Hitchcock. (1996) Screening and Treatment of Sexually Transmitted Diseases. AIDS Patient Care and STDs 10:1, 10-15
    CrossRef

  225. 225

    SHARON S. WEIR, PAUL J. FELDBLUM. (1996) Condom Use to Prevent Incident STDs. Sexually Transmitted Diseases 23:1, 76-77
    CrossRef

  226. 226

    JONATHAN M. ZENILMAN, NANCY ELLISH, ANNE ROMPALO, CAROL WEISMAN, EDWARD W. HOOK, DAVID CELENTANO. (1996) In Response: Condom Use to Prevent Incident STDs. Sexually Transmitted Diseases 23:1, 79-82
    CrossRef

  227. 227

    KORAY TANFER, SEVGI O. ARAL. (1996) Sexual Intercourse During Menstruation and Self-Reported Sexually Transmitted Disease History Among Women. Sexually Transmitted Diseases 23:5, 395-401
    CrossRef

  228. 228

    M. O. ROBBIE JOSSENS, BRENDA ESKENAZI, JULIUS SCHACHTER, RICHARD L. SWEET. (1996) Risk Factors for Pelvic Inflammatory Disease. Sexually Transmitted Diseases 23:3, 239-247
    CrossRef

  229. 229

    CHRISTINE GALAVOTTI, REBECCA CABRAL, CAROLYN BEEKER. (1996) Condom Use to Prevent Incident STDs. Sexually Transmitted Diseases 23:1, 77-79
    CrossRef

  230. 230

    Gary J. Burkholder, Lisa L. Harlow. (1996) Using structural equation modeling techniques to evaluate HIV risk models. Structural Equation Modeling: A Multidisciplinary Journal 3:4, 348-368
    CrossRef

  231. 231

    Michael P. Carey, Seth C. Kalichman. (1995) Letter to the editor. Archives of Sexual Behavior 24:6, 655-661
    CrossRef

  232. 232

    Z A Stein. (1995) More on women and the prevention of HIV infection.. American Journal of Public Health 85:11, 1485-1488
    CrossRef

  233. 233

    J A Catania, D Binson, M M Dolcini, R Stall, K H Choi, L M Pollack, E S Hudes, J Canchola, K Phillips, J T Moskowitz. (1995) Risk factors for HIV and other sexually transmitted diseases and prevention practices among US heterosexual adults: changes from 1990 to 1992.. American Journal of Public Health 85:11, 1492-1499
    CrossRef

  234. 234

    Lisa Armistead, Rex Forehand. (1995) For Whom the Bell Tolls: Parenting Decisions and Challenges Faced by Mothers Who Are HIV Seropositive. Clinical Psychology: Science and Practice 2:3, 239-250
    CrossRef

  235. 235

    Robert J. Ligthelm, Alexander G. C. Bauer, Pieter J. Wismans. (1995) Case Studies of Acute HIV-1 Infections Acquired While Visiting Subsaharan Africa. Journal of Travel Medicine 2:3, 196-198
    CrossRef

  236. 236

    S K Hira, A B Spruyt, P J Feldblum, M R Sunkutu, L H Glover, M J Steiner. (1995) Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia.. American Journal of Public Health 85:8 Pt 1, 1098-1103
    CrossRef

  237. 237

    D.A.A Verkuyl. (1995) Practising obstetrics and gynaecology in areas with a high prevalence of HIV infection. The Lancet 346:8970, 293-296
    CrossRef

  238. 238

    Jonathan Thomas Fanburg, David W. Kaplan, Kelly E. Naylor. (1995) Student Opinions of Condom Distribution at a Denver, Colorado, High School. Journal of School Health 65:5, 181-185
    CrossRef

  239. 239

    Beverly Powis, Paul Griffiths, Michael Gossop, John Strang. (1995) Heterosexual anal intercourse, health risks and drug use: A review with special attention to drug users. Drug and Alcohol Review 14:2, 223-229
    CrossRef

  240. 240

    J. K. Rockstroh, S. Ewig, T. Bauer, H. J. Dengler, T. Sauerbruch, G. Lüchters, J. Oldenburg, H. H. Brackmann, Elke Bailly, R. Kaiser, K. E. Schneweis. (1995) Male-to-female transmission of HIV in a cohort of hemophiliacs — Frequency, risk factors and effect of sexual counseling. Infection 23:1, 29-32
    CrossRef

  241. 241

    (1994) Heterosexual Transmission of HIV. New England Journal of Medicine 331:25, 1717-1719
    Full Text

  242. 242

    Johnson, Anne M., . (1994) Condoms and HIV Transmission. New England Journal of Medicine 331:6, 391-392
    Full Text

Letters